Reaktionsgleichung
C1C=C(Cl)C=C(C(OO)=[O:9])C=1.[Cl:12][C:13]1[C:18]([CH:19]=[CH2:20])=[CH:17][C:16]([C:21]#[N:22])=[CH:15][C:14]=1[NH:23][C:24]1[N:29]=[C:28]([NH:30][CH:31]2[CH2:33][CH2:32]2)[C:27]2=[N:34][CH:35]=[C:36]([C:37]#[N:38])[N:26]2[N:25]=1>C(Cl)(Cl)Cl>[Cl:12][C:13]1[C:18]([CH:19]2[CH2:20][O:9]2)=[CH:17][C:16]([C:21]#[N:22])=[CH:15][C:14]=1[NH:23][C:24]1[N:29]=[C:28]([NH:30][CH:31]2[CH2:32][CH2:33]2)[C:27]2=[N:34][CH:35]=[C:36]([C:37]#[N:38])[N:26]2[N:25]=1Komponenten
4
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
Added MCPBA (70% wet, 3330 mg, 13.5 mmol) in portions to an ice-cooled suspension of 2-((2-chloro-5-cyano-3-vinylphenyl)amino)-4-(cyclopropylamino)imidazo[2,1-f][1,2,4]triazine-7-carbonitrile (Example 399)(339 mg, 0.900 mmol) in CHCl3 (90 mL). The bath was removed and the reaction was left stirring at room temperature for 2 days. This was diluted with CHCl3 and washed with 5% aq. NaHSO3 solution and then 3 times 1 N Na2CO3 solution. After drying with sodium sulfate, the solvent was removed and radial silica gel chromatography eluting with DCM containing 0 to 10% EtOAc afforded 2-((2-chloro-5-cyano-3-(oxiran-2-yl)phenyl)amino)-4-(cyclopropylamino)imidazo[2,1-f][1,2,4]triazine-7-carbonitrile (293 mg) as a white solid.
Aufarbeitung
- temperaturecooled
- customThe bath was removed
- waitthe reaction was left
- additionThis was diluted with CHCl3
- washwashed with 5% aq. NaHSO3 solution
- dry with materialAfter drying with sodium sulfate
- customthe solvent was removed
- washradial silica gel chromatography eluting with DCM containing 0 to 10% EtOAc
Quellen und Nachweise
- ORD-Eintrag
- ord-7d97d56a8d374dccb3dbeb7957ee56b8
- Quelldatensatz
- uspto-grants-2016_03
- Patentnummer
- US09273057B2
Verknüpfte Notizen
Wird geladen…